In NASH patients, a variety of inflammatory cytokines rise gradually, exerting different influences on RBP4 expression, so the net concentration of circulating RBP4 can’t keep up with HFC. Here, RBP4 is linked to metabolic dysfunction-associated steatohepatitis.